Design & Engineering Readiness
Gaps in design maturity, engineering documentation, and manufacturability that make a working prototype harder to industrialize than it looks.
If you’re developing a new medical device or IVD platform, moving from an Alpha or Beta prototype toward a pilot build, or preparing for design transfer and manufacturing scale-up, you’re in the right place. This is where the real work begins – turning a working concept into something that can pass regulatory scrutiny and hold up in high-volume production.
Whether you need design, engineering, QARA, and manufacturing support for a single program, or you’re looking for a long-term CDMO partner to own your product’s full lifecycle, we’re built to engage at whichever stage you’re at.
Many MedTech startups reach a critical stage where the product works technically, but still faces gaps that stand between them and a regulated, market-ready device.
Gaps in design maturity, engineering documentation, and manufacturability that make a working prototype harder to industrialize than it looks.
BOM costs that don't scale, and supplier readiness that hasn't been stress-tested for volume production.
Incomplete risk management, regulatory documentation, and verification & validation planning — the foundation regulators and notified bodies will scrutinize first.
Unresolved questions around manufacturing transfer, production scale-up, and what happens to the product post-launch.
When these functions operate in silos, innovation slows and program risk increases. Closing these gaps early is what separates a working prototype from a product that's ready for regulated markets.
Integrated support across design, manufacturing, compliance, and lifecycle management — helping MedTech companies move from concept to regulated, scalable products.
Consult UsSystems engineering, electronics, mechanical design, firmware, software, industrial design, usability, and testability — concept-to-prototype development built for manufacturability from day one.
Explore Design & EngineeringNPI, pilot builds, and commercial-scale production across ISO 13485-certified, US FDA-registered, cGMP-compliant facilities — including DFM/DFA/DFT and cost optimization along the way.
Explore ManufacturingISO 13485-aligned QMS support, design controls, risk management, technical documentation, supplier quality, audit readiness, and regulatory pathway support across FDA, EU MDR, MDSAP, UK MHRA, Japan's MHLW, Health Canada, and India's CDSCO.
Explore QARA & ComplianceSustaining engineering, ECOs, CAPA support, obsolescence management, cost-down, supplier changes, field issue support, and post-market surveillance.
Explore Lifecycle ManagementCustomer Situation
Idea or clinical need
Our Support
Product definition, feasibility, architecture
Customer Situation
Early working prototype
Our Support
Engineering review, design gaps, DFM roadmap
Customer Situation
Design-intent prototype
Our Support
Pilot readiness, QARA, test strategy
Customer Situation
Controlled units needed
Our Support
NPI, process setup, pilot manufacturing
Customer Situation
Design is stable
Our Support
Design transfer, process validation, scale-up
Customer Situation
Product already in market
Our Support
PLM, cost-down, sustaining engineering
We support MedTech companies ranging from early-stage funded startups to Fortune 500 OEMs, with an expansive footprint across India, Europe, and the U.S. — bringing regulated, manufacturable products to market at speed and scale.
ISO 13485-certified, US FDA-registered facilities · cGMP-compliant manufacturing with Class 100,000 cleanrooms · QMS aligned to ISO 13485, MDSAP, FDA QSR (21 CFR Part 820), EU MDR, UK MHRA, Japan's MHLW, Health Canada, and India's CDSCO · First Indian electronic medical equipment manufacturer to receive MDSAP certification
Every engagement — from an initial design review to full commercial manufacturing — begins under NDA. Your product data, designs, and roadmap remain confidential and remain yours, always.
A track record of measurable outcomes across design, manufacturing, and regulatory execution.
40–60% Reduction
50–75% Faster
30–40% Savings
60–70% Reduction
15–25% Savings
80+ Countries Supported
Backed by execution across 20+ 510(k) platform submissions and reusable solution accelerators spanning RF, laser, IVD, point-of-care, wearable, and connected therapy devices.
“
“
“Our role isn't just to manufacture a device — it's to help innovators turn an idea into a product that's ready for the realities of a regulated market, without losing speed. That's the promise we make to every partner, from first prototype to full-scale production.”
Design optimization and manufacturing validation to ensure optical accuracy, process stability, and scalable production readiness.
DFM, value engineering, and supply chain stabilization enabling sustained manufacturing, reduced costs, and long-term production readiness.
Design optimization, manufacturing scale-up, and regulatory integration enabling a compact, high-accuracy diagnostic platform for global point-of-care deployment.
A unified MedTech CDMO model built to help innovators move from concept to commercialization with speed, quality, and regulatory confidence.
End-to-end services across the entire product lifecycle — design, engineering, QARA, manufacturing, and lifecycle support, all under one roof.
An efficient value chain that enables 30–40% quicker concept-to-commercialization, so your product reaches regulated markets sooner.
Engage through GCC support, BOT, contract manufacturing, India-entry partnerships, or joint ventures.
We're not just a service provider — we're a committed partner invested in your outcomes from prototype through commercial scale.
Breakthrough advancements across IVD, medical aesthetics, pain management, and surgical technologies.
Presence across India, the U.S., and Europe for customer proximity, local support, and regulatory alignment.
A MedTech CDMO supports a device across its full lifecycle — product strategy, design and engineering, QARA, pilot builds, commercial manufacturing, and post-launch support — under one accountable partner, rather than just building to a finished design.
No — this is often the ideal stage. Engaging early means design gaps, manufacturability issues, and regulatory needs get flagged before they become costly to fix.
Yes. All engagements begin under NDA, and your designs, data, and roadmap remain yours throughout.
Our QMS is aligned to ISO 13485, MDSAP, FDA QSR (21 CFR Part 820), EU MDR, UK MHRA, Japan’s MHLW, Health Canada, and India’s CDSCO.
Yes — 16 manufacturing facilities and 34 high-speed SMT lines support over 5 million PCB units/year, letting us scale from pilot to high-volume production.
Both — from early-stage funded startups to Fortune 500 OEMs.
Diagnostics/IVD, point-of-care, patient monitoring, therapeutic, wearable/connected devices, electro-medical, digital-health hardware, rehabilitation devices, and critical care equipment.
16 manufacturing sites and 4 design centers across India, Europe, and the U.S.
Whether you’re at concept, Alpha prototype, Beta prototype, pilot build, manufacturing transfer, or post-launch — we can help you define the next step.